The ENRGISE Pilot Study

Summary

The ENRGISE Pilot Study is a clinical trial^[1].

Key Facts

• The ENRGISE Pilot Study is in the country of United States^[2].
• The ENRGISE Pilot Study's instance of is recorded as clinical trial^[3].
• The ENRGISE Pilot Study's start time is recorded as +2016-04-26T00:00:00Z^[4].
• The ENRGISE Pilot Study's end time is recorded as +2018-06-22T00:00:00Z^[5].
• The ENRGISE Pilot Study's sponsor is recorded as University of Florida^[6].
• The ENRGISE Pilot Study's main subject is recorded as inflammation^[7].
• The ENRGISE Pilot Study's number of participants is recorded as {'unit': '1', 'amount': '+105'}^[8].
• The ENRGISE Pilot Study's title is recorded as The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Study^[9].
• The ENRGISE Pilot Study's short name is recorded as ENRGISE^[10].
• The ENRGISE Pilot Study's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+70'}^[11].
• The ENRGISE Pilot Study's ClinicalTrials.gov ID is recorded as NCT02676466^[12].
• The ENRGISE Pilot Study's research intervention is recorded as losartan^[13].
• The ENRGISE Pilot Study's clinical trial phase is recorded as phase II clinical trial^[14].
• The ENRGISE Pilot Study's research site is recorded as Northwestern University^[15].
• The ENRGISE Pilot Study's research site is recorded as Tufts University School of Arts and Sciences^[16].
• The ENRGISE Pilot Study's research site is recorded as Wake Forest University^[17].
• The ENRGISE Pilot Study's research site is recorded as University of Pittsburgh^[18].
• The ENRGISE Pilot Study's research site is recorded as University of Florida^[19].
• The ENRGISE Pilot Study's study type is recorded as interventional study^[20].